Anna L. David

Has grant

University Name
Country flag
United Kingdom

Research Interests

Explore related searches

Contact this professor

Recent Grants

Grant: Close

Rotation of the fetal head at full cervical dilatation

Open Date: 2021-06-01

Close Date: 2025-08-01

Grant: Close

Fetoscopic repair of fetal spina bifida and tracheal occlusion for congental diaphragmatic hernia

Open Date: 2020-11-01

Close Date: 2025-10-01

Grant: Close

COVID-19: Assessing the vulnerability of the fetus to SARS-CoV2 infection across development

Open Date: 2020-06-01

Close Date: 2021-05-01

Grant: Close

Risk of preterm birth in women who conceive following bone marrow transplantation in childhood

Open Date: 2020-01-01

Close Date: 2021-07-01

Grant: Close

PREDICT study: Predicting preterm birth after surgical intervention in twin pregnancies

Open Date: 2019-09-01

Close Date: 2021-08-01

Articles (11)

Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review

Objective To investigate the maternal and fetal safety of In utero stem cell transplantation (IUSCT). Methods Medline®, Embase and Cochrane library (1967−2023) search for publications reporting IUSCT in humans. Two reviewers independently screened abstracts and full‐text papers. Results Sixty six transplantation procedures in 52 fetuses were performed for haemoglobinopathies ( n = 14), red cell/bleeding disorders ( n = 4), immunodeficiencies ( n = 15), storage disorders ( n = 7), osteogenesis imperfecta ( n = 2) and healthy fetuses ( n = 10). The average gestational age was 18.9 weeks; of procedures reporting the injection route, cells were delivered by intraperitoneal ( n = 37), intravenous ( n = 19), or intracardiac ( n = 4) injection or a combination ( n = 3); most fetuses received one injection ( n = 41). Haematopoietic ( n = 40) or mesenchymal ( n = 12) stem cells were delivered. The cell dose was inconsistently reported (range 1.8−3.3 × 10 9 cells total ( n = 27); 2.7−5.0 × 10 9 /kg estimated fetal weight ( n = 17)). The acute fetal procedural complication rate was 4.5% (3/66); the acute fetal mortality rate was 3.0% (2/66). Neonatal survival was 69.2% (36/52). Immediate maternal and pregnancy outcomes were reported in only 30.8% (16/52) and 44.2% (23/52) of cases respectively. Four fetal/pregnancy outcomes would also classify as ≥ Grade 2 maternal adverse events. Conclusions Short‐, medium‐, and long‐term maternal and fetal adverse events should be reported in all IUSCT studies.

Year:

2023

Cx43 regulates mechanotransduction mechanisms in human preterm amniotic membrane defects

Objective The effects of mechanical stimulation in preterm amniotic membrane (AM) defects were explored. Methods Preterm AM was collected from women undergoing planned preterm caesarean section (CS) due to fetal growth restriction or emergency CS after spontaneous preterm prelabour rupture of the membranes (sPPROM). AM explants near the cervix or placenta were subjected to trauma and/or mechanical stimulation with the Cx43 antisense. Markers for nuclear morphology (DAPI), myofibroblasts (αSMA), migration (Cx43), inflammation (PGE 2 ) and repair (collagen, elastin and transforming growth factor β [TGFβ 1 ]) were examined by confocal microscopy, second harmonic generation, qPCR and biochemical assays. Results In preterm AM defects, myofibroblast nuclei were highly deformed and contractile and expressed αSMA and Cx43. Mechanical stimulation increased collagen fibre polarisation and the effects on matrix markers were dependent on tissue region, disease state, gestational age and the number of fetuses. PGE 2 levels were broadly similar but reduced after co‐treatment with Cx43 antisense in late sPPROM AM defects. TGFβ 1 and Cx43 gene expression were significantly increased after trauma and mechanical stimulation but this response dependent on gestational age. Conclusion Mechanical stimulation affects Cx43 signalling and cell/collagen mechanics in preterm AM defects. Establishing how Cx43 regulates mechanosignalling could be an approach to repair tissue integrity after trauma.

Year:

2023

Collaborators (13)

Yada Kunpalin

Mount Sinai Hospital

CANADA

Jan Deprest

-

BELGIUM

Simon Waddington

Professor of Gene Therapy

University College London

UNITED KINGDOM

Amanda Sferruzzi-Perri

University Lecturer in Reproductive Physiology (proleptic appointment)

University of Cambridge

UNITED KINGDOM

Emily Cornish

NIHR Academic Clinical Lecturer in Obstetrics and Maternal Fetal Medicine Subspecialty Trainee

University College London

UNITED KINGDOM

Sara Hillman

Associate Professor

University College London

UNITED KINGDOM

Rebecca Spencer

University of Leeds

UNITED KINGDOM

Luc Joyeux

Assistant Professor, Attending Pediatric and Fetal Surgeon & Senior research scientist

Baylor College of Medicine

UNITED STATES

Neil Marlow

Emeritus Professor of Neonatal Medicine

University College London

UNITED KINGDOM

Andrew Melbourne

King’s College London

UNITED KINGDOM

Ahad Rahim

University College London

UNITED KINGDOM

Dimitrios Siassakos

Professor & Consultant in Obstetrics

University College London

UNITED KINGDOM

Tina T. Chowdhury

-

UNITED KINGDOM
Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI